This program provides ovarian cancer patients with up-to-date information on innovative treatment strategies, including HIPEC (Hyperthermic Intraperitoneal Chemotherapy), maintenance therapy, and targeted treatments guided by tumor molecular profiling.
Zoom Link Sent Upon Registration
Monday, September 8th, 8pm EST/5pm PST
This program provides ovarian cancer patients with up-to-date information on innovative treatment strategies, including HIPEC (Hyperthermic Intraperitoneal Chemotherapy), maintenance therapy, and targeted treatments guided by tumor molecular profiling. It also highlights opportunities to participate in clinical trials, while addressing prevention efforts for those with hereditary genetic risk and survivorship.
Bonus for our Embrace Community: We invite members of our Embrace community, those facing metastatic breast cancer or advanced ovarian cancer, to stay on at the end of the webinar for an intimate breakout session with our experts and Bonnie Beckoff, Director of Sharsheret Support Services.
Questions? Contact Bonnie Beckoff at [email protected].
Speaker Bios
Beth Y. Karlan, MD, is Professor and Vice Chair in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA. She holds the Nancy Marks endowed chair in Women’s Health Research and is the Director of Cancer Population Genetics at the UCLA Jonsson Comprehensive Cancer Center. Her research focuses on early detection and precision prevention for ovarian and other gynecologic malignancies as well as on identifying biomarkers to personalize treatments and improve patient outcomes. Recognized as an authority on inherited cancer risk, Dr. Karlan has contributed to the development of treatment guidelines and novel therapies for these patients. To date, her scholarly work has resulted in more than 500 peer-reviewed research publications.
Dr. Karlan is an American Cancer Society Clinical Research Professor, a member of the National Academy of Medicine, and the National Cancer Policy Forum. She has served in many national leadership roles, including president of the Society of Gynecologic Oncology, member of the National Cancer Advisory Board, and editor-in-chief of the scientific journal Gynecologic Oncology. Her contributions have been recognized by her peers with multiple awards, including a Lifetime Achievement Award from the International Society of Gynecologic Cancer.
Disclaimer: By joining this program I understand and acknowledge that Sharsheret is not providing medical advice. Additionally, I release and waive Sharsheret from any liability in the event of any accident or injury I may incur either during the course of this webinar or in performing any of the activities discussed during the same.
All views shared on the webinar are of the speakers and are independent of the program sponsors. To the best knowledge of Sharsheret, no relationship exists between the sponsors and the speakers, and no payment has or will be made by the sponsor to the speakers in connection with this webinar.
